digilib@itb.ac.id +62 812 2508 8800

ABSTRAK Juanita A/P Selvaraja
PUBLIC yana mulyana

Vaccines are now known as the best intervention for ending the current ongoing COVID-19 pandemic. However, there was a delay among Malaysian citizens in the acceptance of the COVID-19 vaccine. Therefore COVID-19 vaccine hesitancy seems to be a real concern as it is still evident despite the improvement of medical healthcare system around the world. This study is aimed to analyse COVID-19 vaccination acceptance and post COVID-19 vaccination syndrome among Malaysians. This study was a questionnaire based retrospective study among Malaysian citizens whom are 15 years and above and a total of 224 respondents have participated in this survey. Result showed that respondents indicated higher prevalence in the willingness to receive vaccination for both first and second dose (83.5%), (86.2%). However, there were no significant differences in the ratings of vaccination knowledge and the willingness to receive vaccination (p = 0.428), (p = 0.416). In addition, there is a significant difference in the ratings of the side effects after receiving their first dose and the vaccine brand that respondents have received (p=0.000). There were two types of vaccine that was provided for the respondents which are viral vector vaccines and whole inactive virus vaccines. Most respondents have experienced a higher percentage of experiencing side effects after receiving viral vector vaccines (85.0-87.3 %). Fever and muscle pain have been listed has the highest percentage of respondents whom have experienced clinical occurrence after both first (47.3%),(45.5%) and second dose with (42.9%),(39.3%) respectively. In general, respondents in Malaysia showed their optimism in receiving the vaccination willingly. Moreover, study shows that viral vector vaccines cause higher prevalence of side effects among Malaysians compared to whole inactive virus vaccines.